K. Zheng et al. Gold-nanoparticle-based multistage drug delivery system for antitumor therapy

Author:

Zheng Kaikai12,Zhou Dong13,Wu Lili4,Li Jian1,Zhao Bing1,Zhang Shihao5,He Ruiying2,Xiao Lan67,Zoya Iqbal5,Yu Li28,Zhang Yuhong2,Li Yulin25,Gao Jie4,Li Kaichun1ORCID

Affiliation:

1. Department of Oncology, Shanghai Fourth  People’s Hospital, Tongji University School of Medicine, Shanghai, China

2. Hubei Collaborative Innovation Center for Advanced Organic Chemical Materials, Key Laboratory for the Synthesis and Application of Organic Functional Molecules of Ministry of Education, Key Laboratory for the Green Preparation and Application of Functional Materials of Ministry of Education, College of Chemistry and Chemical Engineering, Hubei University, Wuhan, China

3. School of Chemistry and Chemical Engineering, Nanchang University, Nanchang, China

4. Changhai Clinical Research Unit, Shanghai Changhai Hospital, Naval Medical University, Shanghai, China

5. Key Laboratory for Ultrafine Materials of Ministry of Education, Engineering Research Centre for Biomedical Materials of Ministry of Education, East China University of Science and Technology, Shanghai, China

6. Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove Campus, Brisbane, Queensland, Australia

7. The Australia-China Centre for Tissue Engineering and Regenerative Medicine (ACCTERM), Brisbane, Queensland, Australia

8. Department of Trauma Orthopedics and Microsurgery, Zhongnan Hospital of Wuhan University, Wuhan, China

Funder

the scientific research project of Hongkou District Health Committee of Shanghai

the special project of clinical research of the health industry of Shanghai Municipal Health Commission

the funding grant from Shanghai International Cooperation Program

the National Natural Science Foundation of China

the National Key R&D Program of China

the research project of Shanghai Fourth People’s Hospital

the National Natural Science Foundation of China for Innovative Research Groups

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3